Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2026-01-25 @ 11:14 PM
Study NCT ID:
NCT03279692
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-03
First Post:
2017-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
Sponsor:
Organization: